TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial.

Peter A Fasching et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.